NEAT1–SOD2 Axis Confers Sorafenib and Lenvatinib Resistance by Activating AKT in Liver Cancer Cell LinesHiroyuki Tsuchiya, Kenji Yoshida|Current Issues in Molecular Biology|2023Cited by 24